QAMZOVA
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99060475
- Mark type
- Stylized text
- Filed
- 27 Feb 2025
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Yue (Robert) Xu
Goods and services
- Class 005 — Pharmaceuticals: Medicines made of Chinese traditional medicinal herbs; Medicines for human purposes in the nature of pain relief medications; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for skin care, skin regeneration, skin moisturization, and aesthetic skin treatments to treat skin disorders; Pre-filled syringes for medical purposes sold filled with hyaluronic acid and Botulinum toxin; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports related injuries, cerebral palsy, muscle spasms, tremors and pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for blood infusions, pharmaceutical preparations, specifically, dantrolene sodium for injections, and emergency pharmaceutical preparations containing diluents and active pharmaceutical ingredients for the treatment of wounds; Analgesics; Biochemical medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; Dietetic foods adapted for medical purposes; Medicines for veterinary purposes for the treatment of infectious diseases, viral conditions, skin conditions, pain, and inflammation; First aid kits; First-aid boxes, filled
Owner
- NANJING DELOVA BIOTECH CO., LTD., Nanjing, Jiangsu, CN
- NANJING DELOVA BIOTECH CO., LTD., Nanjing, Jiangsu, CN
Prosecution history
- 20 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Jun 2025 — NON-FINAL ACTION E-MAILED
- 10 Jun 2025 — NON-FINAL ACTION WRITTEN
- 02 Jun 2025 — ASSIGNED TO EXAMINER
- 27 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED